A prospective randomised multicentre phase III clinical trial comparing the effects of PANOREX [edrecolomab] injection plus 5-fluorouracil (5-FU)/leucovorin [folinic acid] versus 5-fluorouracil/leucovorin versus PANOREX alone, in patients with surgically resected stage III (Dukes C) carcinoma of the colon

Trial Profile

A prospective randomised multicentre phase III clinical trial comparing the effects of PANOREX [edrecolomab] injection plus 5-fluorouracil (5-FU)/leucovorin [folinic acid] versus 5-fluorouracil/leucovorin versus PANOREX alone, in patients with surgically resected stage III (Dukes C) carcinoma of the colon

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Dec 2007

At a glance

  • Drugs Edrecolomab; Fluorouracil; Folinic acid
  • Indications Colon cancer
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 19 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top